Article

Dean McGee Eye Institute dedicates facility

A 78,000-square-foot research and clinical facility has been dedicated at the Dean McGee Eye Institute. It doubles the research laboratory space, expands clinical capacity by 40%, and consolidates all of the institute’s clinical care, vision research, teaching, and administrative functions into one location.

Oklahoma City-A 78,000-square-foot research and clinical facility has been dedicated at the Dean McGee Eye Institute. It doubles the research laboratory space, expands clinical capacity by 40%, and consolidates all of the institute’s clinical care, vision research, teaching, and administrative functions into one location.

The $46 million, five-story building adjoins the existing original facility built in 1975.

“The tremendous growth of the institute and our success in recruiting some of the nation's leading research and clinical talent over the [past] two decades created crowded conditions and forced us to expand into other facilities,” said Gregory Skuta, MD, president and chief executive officer of the Dean McGee Eye Institute and the Edward L. Gaylord Professor and chairman of the Oklahoma University College of Medicine's department of ophthalmology. “This remarkable new building will foster closer and more effective communication and collaboration as we continue to attract some of the finest minds in the country in vision care and research.”

The institute's clinical and surgical teams provide more than 150,000 patient visits and 7,000 surgical procedures each year. In addition, the institute houses the ophthalmology department for the University of Oklahoma College of Medicine.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
© 2025 MJH Life Sciences

All rights reserved.